MDT perspectives on how GLP-1 RAs can reduce stroke risk episode artwork

EPISODE · Nov 17, 2022 · 14 MIN

MDT perspectives on how GLP-1 RAs can reduce stroke risk

from touchPODCAST · host touchpodcast

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D The multidisciplinary team Primary care physician: Dr Yassir Javaid, Northamptonshire, UK Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece This touchPODCAST is for HCPs only.   This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurology.com/cme/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d/ 

Episode metadata supplied by the publisher feed · Published Nov 17, 2022

Embed this episode

Ready to play

MDT perspectives on how GLP-1 RAs can reduce stroke risk

0:00 14:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 14 minutes long.

When was this touchPODCAST episode published?

This episode was published on November 17, 2022.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!